Investors are bullish on homebuilders in 2026 due to restricted U.S. housing supply, existing homeowners with low mortgage rates staying put, the expectation of declining mortgage rates, Washington’s plan to increase housing supply, and robust estimates for companies like DR Horton and Lennar.

Zacks’ Research Chief picks a stock with the potential to at least double, among their Top 5 recommendations. This stock is believed to surpass earlier recommendations like Hims & Hers Health, which saw a significant increase. Check out the top stock and four runners-up for potential growth.

Read more at Nasdaq: Why “Golden Handcuffs” are a Gift to Homebuilders in 2026